I-ASRM ishicilela imininingo yezokwelapha ye-Conceive Plus
Siyaqhenya ngezifundo eziningi esizenzile ukuqinisekisa ubunjalo obuyingqayizivele be-Conceive Plus. Ngo-Okthoba 2009 izifundo zethu zethulwa e 2009 Annual Meeting of the American Society for Reproductive Medicine. Chofoza ukuze ubuke izifundo ezishicilelwe I-Conceive Plus® yagunyazwa njengephephile ukuthi isetshenziswe ngabalingani abazama ukukhulelwa yi-Food and Drug Administration (FDA) ngomhlaka 7 Novemba 2013 ngaphansi kwe-510(k): K131355. I-Conceive Plus® iyavumelana nesidoda somuntu, ama-oocyte nama-embryo futhi iphephile ukusetshenziswa ngabalingani abazama ukukhulelwa.
Ikhodi yomkhiqizo: PEB (lubricant, personal, gamete, fertilization, and embryo compatible) Class II (21 CFR 884.5300)






